Point-of-Care (POC) Coagulation Testing Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

The Business Research Company recently released a comprehensive report on the Global Point-of-Care (POC) Coagulation Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.12 billion in 2023 to $1.18 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

Market Drivers and Trends:

The rising incidence of cardiovascular diseases is expected to propel the growth of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders of the heart and blood vessels, including conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is helpful in the treatment of cardiovascular diseases (CVDs) as it provides real-time information on coagulation status, enabling timely decision-making on coagulation interventions and reducing the risk of bleeding complications after cardiac surgery. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in the United States, heart disease claimed the lives of about 695,000 people in 2021, accounting for 1 in 5 fatalities. Further, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the point-of-care (POC) coagulation testing market.

Major companies operating in the point-of-care (POC) coagulation testing market are focused on strategic collaborations to gain a competitive edge in the market. Strategic collaboration is a formal agreement between two or more parties to work together toward achieving specific, predetermined goals that are mutually beneficial. For instance, in October 2021, Trivitron Healthcare, an Indian-based medical devices company, collaborated with Diagon Ltd., a US-based manufacturer of IVD products, and Vanguard Diagnostics, an Indian-based manufacturer of diagnostic products, to launch Coagulation Analyzer products. It provides accurate and efficient coagulation testing, and the collaboration aims to improve patient diagnosis and management. The diverse range of analyzers caters to various healthcare settings, making coagulation testing more accessible.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

Major Key Players of the Market:

AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

Point-of-Care (POC) Coagulation Testing Market 2024 Key Insights:

• The point-of-care (poc) coagulation testing market is expected to grow to $1.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%.
• Cardiovascular Disease Rates Fuel Expansion Of POC Coagulation Testing Market
• Increasing Focus On Innovating With Connected POC Coagulation Solutions In A Competitive Market
• North America was the largest region in the point-of-care (POC) coagulation testing market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13913&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.